The GLP-1 Revolution Is Exposing a Clinical Nutrition Gap

A major shift in diabetes and obesity treatment is underway as GLP-1 medications reach a rapidly growing share of American patients. A 2025 KFF poll found that 12% of U.S. adults were taking a GLP-1 medication, while 18% had used one at some point. These drugs imitate a hormone involved in blood-sugar control, slow digestion and help people feel full sooner. Some medications frequently discussed within the same category also act on an additional hormone pathway.

That change in appetite is central to the medications’ effectiveness, but it also changes the nutritional demands of treatment. A multidisciplinary advisory published in The American Journal of Clinical Nutrition reported that GLP-1 use can reduce daily calorie intake by 16% to 39%. When someone begins eating substantially less, every meal carries more nutritional responsibility. Protein, fiber, vitamins, minerals and hydration must fit into a much smaller amount of food.

Emerging research suggests that many patients may struggle to make that adjustment independently. A 2026 preliminary study published in the Journal of Translational Medicine involving 387 adults using GLP-1 or dual GIP and GLP-1 medications recorded an average daily intake of 753 calories, including 33.4 grams of protein and 7.2 grams of fiber. Fewer than 10% of participants met the recommended intake for protein, fiber, vitamin D, calcium or potassium. The study does not represent every patient, but it exposes a consequential weakness in the current treatment conversation. Eating less and eating adequately are two different outcomes.

The need for nutritional support extends beyond food intake. A 2025 International Journal of Obesity review involving 33,354 people identified nausea, vomiting, diarrhea and constipation as the most common gastrointestinal effects of GLP-1 medications. These findings reinforce the need for practices to monitor symptoms, assess nutritional intake and provide continuing support throughout treatment.

Jena Salisbury, founder of Innate Clinical Nutrition, believes this is where many practices encounter difficulty. Drawing on more than 13 years in clinical nutrition and functional medicine, she argues that healthcare’s central nutrition challenge involves implementation. “Nutrition cannot remain a conversation that happens around treatment,” Salisbury says. “It needs to be built into the care pathway so patients receive structured support as their treatment and nutritional needs evolve.”

Salisbury says that perspective developed while she was helping medical practices introduce functional health services. She frequently encountered clinics that had invested in supplements, testing and treatment modalities without establishing a connected process for staff education or patient follow-through. In her view, adding services without a clear pathway can leave clinicians and employees uncertain about how each element fits into the patient’s broader care.

GLP-1 therapy makes that disconnect especially visible, Salisbury explains, because reduced appetite does not automatically produce nutritionally complete eating. Patients may need support with meal structure, protein, hydration, digestion and changing symptoms, all within the boundaries established by their prescribing clinician. “A powerful medication still operates within a whole person,” she says. “The patient needs a nutritional foundation that can support the treatment, reveal emerging concerns and help the clinical team make better-informed decisions.”

Innate Clinical Nutrition develops structured nutrition programs that healthcare practices and practitioners can integrate into their services. Its Burn & Balance program, which Salisbury identifies as particularly relevant to practices working with GLP-1 patients, provides a standardized nutritional foundation that can be supplemented with individualized clinical assessment. She describes the model as a starting framework rather than a universal diet, allowing qualified practitioners to refine care according to a patient’s history, laboratory findings, response and medical needs.

According to Salisbury, the distinction matters because functional nutrition is inherently individualized. “Establishing consistent fundamentals does not eliminate precision. It gives clinicians a clearer baseline from which to observe patterns and determine where personalization may be appropriate,” she says. She also uses her CNS Unfiltered podcast to discuss how Certified Nutrition Specialists can contribute research-informed nutrition expertise across medicine, mental healthcare, aesthetics and other clinical settings.

Healthcare will continue developing medications, diagnostics and personalized interventions. Salisbury believes nutrition systems must advance alongside them. “Healthcare does not need another flood of nutrition information,” she says. “It needs qualified professionals, defined responsibilities and practical systems that make nutrition part of what happens every day. When implementation becomes routine, clinical nutrition can function as healthcare infrastructure rather than an optional addition.”

This article is for informational purposes only and does not substitute for professional medical advice. If you are seeking medical advice, diagnosis or treatment, please consult a medical professional or healthcare provider. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Members of the editorial and news staff of Woman’s World were not involved with the creation of this content. All contributor content is reviewed by Woman’s World staff.